Ann E Burelbach, MD | |
5475 S 500 E, Ogden, UT 84405-6905 | |
(801) 479-2111 | |
Not Available |
Full Name | Ann E Burelbach |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 5475 S 500 E, Ogden, Utah |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275594368 | NPI | - | NPPES |
D6282 | Medicaid | UT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207PE0004X | Emergency Medicine - Emergency Medical Services | 285240-1205 (Utah) | Secondary |
207P00000X | Emergency Medicine | 285240-1205 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ann E Burelbach, MD 144 S 500 E, 2nd Floor, Salt Lake City, UT 84102-1907 Ph: () - | Ann E Burelbach, MD 5475 S 500 E, Ogden, UT 84405-6905 Ph: (801) 479-2111 |
News Archive
Vaginal transmission accounts for the majority of new HIV infections worldwide. Forms of pre-exposure prophylaxis (PrEP) such as vaginal gels and vaginal rings designed to prevent HIV transmission have encountered poor efficacy in human trials due to problems with adherence.
Industry Standard Research (ISR Reports) today announced the launch of a substantial research report titled Success in Patient and Investigator Recruitment. This report presents data and analysis from 362 interviews with Patients, Principal Investigators, and Drug development professionals from around the world.
In the largest clinical trial of its kind, researchers show that combining sound and electrical stimulation of the tongue can significantly reduce tinnitus, commonly described as "ringing in the ears." They also found that therapeutic effects can be sustained for up to 12 months post-treatment.
A new study from researchers at the UCLA Jonsson Comprehensive Cancer Center helps explain how disruptions in genes can lead to the resistance to one of the leading immunotherapies, PD-1 blockade, and how new drug combinations could help overcome resistance to the anti-PD-1 therapy in a mechanistically-based way.
The future is looking good for drugs designed to combat Alzheimer's disease. EPFL scientists have unveiled how two classes of drug compounds currently in clinical trials work to fight the disease. Their research suggests that these compounds target the disease-causing peptides with high precision and with minimal side-effects.
› Verified 9 days ago
Robert W Grow, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5475 Adams Ave Pkwy, Ogden, UT 84405 Phone: 801-479-2376 | |
Mrs. Ramsey Lee Gosselin, FNP Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5405 S 500 E Ste 100, Ogden, UT 84405 Phone: 801-475-7966 Fax: 801-475-7967 | |
Robert D Crofts, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-7615 Fax: 801-387-7667 | |
Spencer Page Ferrin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-7001 | |
Thomas E Garrison, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-7615 Fax: 801-387-7667 | |
Kristian Kemp, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5475 S 500 E, Ogden, UT 84405 Phone: 801-479-2111 | |
Mitchell Douglas Barneck, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-7000 |